These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32802815)

  • 21. Poorer Oncologic Outcome of Good Responders to PCRT With Remnant Lymph Nodes Defies the Oncologic Paradox in Patients With Rectal Cancer.
    Cho E; Park IJ; Hong SM; Lee JL; Kim CW; Yoon YS; Lim SB; Yu CS; Kim JC
    Clin Colorectal Cancer; 2019 Jun; 18(2):e171-e178. PubMed ID: 31027968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncologic outcome after preoperative chemoradiotherapy in patients with pathologic T0 (ypT0) rectal cancer.
    Jang TY; Yu CS; Yoon YS; Lim SB; Hong SM; Kim TW; Kim JH; Kim JC
    Dis Colon Rectum; 2012 Oct; 55(10):1024-31. PubMed ID: 22965400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxaliplatin/fluorouracil-based adjuvant chemotherapy for locally advanced rectal cancer after neoadjuvant chemoradiotherapy and surgery: a systematic review and meta-analysis of randomized controlled trials.
    Zhao L; Liu R; Zhang Z; Li T; Li F; Liu H; Li G
    Colorectal Dis; 2016 Aug; 18(8):763-72. PubMed ID: 27169752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. YpT1-2N0 rectal cancer after neoadjuvant chemoradiation has lower survival compared with pT1-2N0 rectal cancer.
    Wan JF; Zhu J; Li GC; Sun WJ; Zhang Z
    Oncotarget; 2015 Dec; 6(38):41056-62. PubMed ID: 26517674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postoperative chemotherapy after neoadjuvant chemoradiation and surgery for rectal cancer: is it essential for patients with ypT0-2N0?
    Huh JW; Kim HR
    J Surg Oncol; 2009 Oct; 100(5):387-91. PubMed ID: 19582821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postmastectomy Radiotherapy After Neoadjuvant Chemotherapy in cT
    Luo M; Chen H; Deng H; Jin Y; Wang G; Zhang K; Ma H; Chen Y; Zhang S; Zhou J
    Front Oncol; 2022; 12():881047. PubMed ID: 35656513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant Chemotherapy Seemed Not to Have Survival Benefit in Rectal Cancer Patients with ypTis-2N0 After Preoperative Radiotherapy and Surgery from a Population-Based Propensity Score Analysis.
    Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai SJ
    Oncologist; 2019 Jun; 24(6):803-811. PubMed ID: 29674444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncologic Outcome of ypT1-2N0 Rectal Cancer After Neoadjuvant Chemoradiotherapy Compared With pT1-2N0 Rectal Cancer.
    Yeop Oh S; Bae Kim Y; Wook Suh K
    Am J Clin Oncol; 2017 Oct; 40(5):512-516. PubMed ID: 26083556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
    Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
    Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxaliplatin-based adjuvant chemotherapy rather than fluorouracil-based chemotherapy in rectal cancer is more efficient to decrease distant metastasis and increase survival after preoperative chemoradiotherapy and surgery: a meta-analysis.
    Song JH; Lee JH; Kim SH; Um JW;
    Int J Colorectal Dis; 2022 Mar; 37(3):649-656. PubMed ID: 35050402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does Adjuvant Chemotherapy for Locally Advanced Resectable Rectal Cancer treated with Neoadjuvant Chemoradiotherapy have an impact on survival? A Single Moroccan Institute Retrospective Study.
    Seddik Y; Brahmi SA; Afqir S
    Gulf J Oncolog; 2019 May; 1(30):29-32. PubMed ID: 31242979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is adjuvant chemotherapy necessary for patients with pathological complete response after neoadjuvant chemoradiotherapy and radical surgery in locally advanced rectal cancer? Long-term analysis of 40 ypCR patients at a single center.
    Zhou J; Qiu H; Lin G; Xiao Y; Wu B; Wu W; Sun X; Lu J; Zhang G; Xu L; Liu Y
    Int J Colorectal Dis; 2016 Jun; 31(6):1163-8. PubMed ID: 27044403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is adjuvant chemotherapy really needed after curative surgery for rectal cancer patients who are node-negative after neoadjuvant chemoradiotherapy?
    Kiran RP; Kirat HT; Burgess AN; Nisar PJ; Kalady MF; Lavery IC
    Ann Surg Oncol; 2012 Apr; 19(4):1206-12. PubMed ID: 21935748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncologic results and prognostic predictors of patients with locally advanced rectal cancer showing ypN0 after radical surgery following neoadjuvant chemoradiotherapy.
    Lee KH; Kim JC; Kim JY; Kim JS
    Int J Colorectal Dis; 2015 Aug; 30(8):1041-50. PubMed ID: 26002751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neoadjuvant chemoradiotherapy determines the prognostic impact of anastomotic leakage in advanced rectal cancer.
    Oh BY; Park YA; Huh JW; Cho YB; Yun SH; Kim HC; Lee WY
    Ann Surg Treat Res; 2022 Oct; 103(4):235-243. PubMed ID: 36304190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is adjuvant chemotherapy necessary for locally advanced rectal cancer patients with pathological complete response after neoadjuvant chemoradiotherapy and radical surgery? A systematic review and meta-analysis.
    Ma B; Ren Y; Chen Y; Lian B; Jiang P; Li Y; Shang Y; Meng Q
    Int J Colorectal Dis; 2019 Jan; 34(1):113-121. PubMed ID: 30368569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant chemotherapy after neoadjuvant chemoradiation and curative resection for rectal cancer: is it necessary for all patients?
    Jung KU; Kim HC; Park JO; Park YS; Park HC; Choi DH; Cho YB; Yun SH; Lee WY; Chun HK
    J Surg Oncol; 2015 Mar; 111(4):439-44. PubMed ID: 25488390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of clinical outcomes of conservative treatment and surgery for esophageal cancer patients who achieve a clinical complete response following neoadjuvant chemoradiotherapy: a systematic review and meta-analysis.
    Sun Z; Zheng J; Xu X; Zhao X; Ma X; Ye Q
    Ann Transl Med; 2022 Dec; 10(24):1378. PubMed ID: 36660656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of clinical and pathological stages on locally advanced rectal carcinoma after neoadjuvant chemoradiotherapy.
    Wen B; Zhang L; Wang C; Huang R; Peng H; Zhang T; Dong J; Xiao W; Zeng Z; Liu M; Gao Y
    Radiat Oncol; 2015 Jun; 10():124. PubMed ID: 26040453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neoadjuvant treatment response as an early response indicator for patients with rectal cancer.
    Park IJ; You YN; Agarwal A; Skibber JM; Rodriguez-Bigas MA; Eng C; Feig BW; Das P; Krishnan S; Crane CH; Hu CY; Chang GJ
    J Clin Oncol; 2012 May; 30(15):1770-6. PubMed ID: 22493423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.